ABSTRACT The development of advanced bone cements is critical for enhancing the performance and longevity of orthopaedic implants. This study introduces a combination synthesis method for producing akermanite (AKT-Ca2MgSi2O7) ceramics and commercial zirconia (ZrO2) bioceramics. This study aims to improve the material’s mechanical strength, bioactivity, and biocompatibility by the incorporation of bioceramics into the polymethyl methacrylate (PMMA) matrix. The PMMA matrix ensures appropriate handling characteristics and setting times suitable for clinical applications. Characterization studies reveal that the composite achieves an optimal balance between bioactivity and mechanical performance. The results indicated that the AKT/PMMA/ZrO2 composite bone cements that were produced exhibited a substantially lower polymerization temperature than pure PMMA. Additionally, they maintained high compressive strength (~105 MPa) and optimal setting times (9–14 minutes). The bioactivity assessment, through simulated body fluid immersion tests, indicates a layer of hydroxyapatite is formed on the composite surface within 7 days, confirming its osteointegration potential. Furthermore, the composite exhibits excellent biocompatibility, with in vitro assays showing over 90% cell viability after 24 hours of culture. Scanning electron microscopy and X-ray diffraction analyses confirm the homogeneous distribution of akermanite and zirconia throughout the PMMA matrix, contributing to ensuring the uniform mechanical characteristics and bioactivity of the composite material.
Read full abstract